Eli Lilly (LLY) PT Raised to $580 at Credit Suisse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Eli Lilly & Co. (LLY) upgraded at Jefferies - sees near-term revenue and EPS upside
August 9, 2023 11:00 AM EDTEli Lilly & Co. (NYSE: LLY) was raised to Buy from Hold at Jefferies on Wednesday, with analyst Akash Tewari raising the price target to $615 per share from $430.
The upgrade follows two positive data points for the pharmaceutical company. Tewari explained that "SELECT showed... More
